Biodel to Report Fourth Quarter Fiscal Year 2013 Financial Results on December
DANBURY, Conn., Dec. 12, 2013 (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD)
will issue its fourth quarter fiscal year 2013 financial results on December
18, 2013. Following the release of the company's financial results, Biodel's
senior management will host a conference call to discuss the results and
provide an update on the company's progress.
December 18, 2013 schedule:
4:30 pm ET: Fourth quarter fiscal year 2013 results will be distributed
4:45 pm ET: Conference call participants should dial:
+1 (877) 303 - 8028(United States) or
+1 (760) 536 - 5167 (International)
5:00 pm ET: Conference call begins
Interested parties may access a live audio webcast of the conference call in
the investor section of Biodel's website at www.biodel.com. The audio webcast
will be archived and available for replay through the website.
About Biodel Inc.
Biodel Inc. is a specialty biopharmaceutical company focused on the
development and commercialization of innovative treatments for diabetes that
may be safer, more effective and more convenient for patients. Biodel's
product candidates are developed by applying proprietary technologies to
existing drugs in order to improve their therapeutic profiles. More
information about Biodel is available at www.biodel.com.
CONTACT: John Graziano, +1 (646) 378 2942
Press spacebar to pause and continue. Press esc to stop.